|1.||Jiang, Yong: 4 articles (01/2014 - 11/2004)|
|2.||Chen, Hong: 3 articles (05/2013 - 12/2007)|
|3.||Zhu, Min: 3 articles (02/2013 - 07/2012)|
|4.||Tu, Peng Fei: 3 articles (04/2012 - 11/2004)|
|5.||Wang, Ye: 2 articles (01/2015 - 01/2015)|
|6.||Zou, Zhihua: 2 articles (01/2015 - 01/2015)|
|7.||Yu, Debin: 2 articles (01/2015 - 01/2015)|
|8.||Dong, Liwei: 2 articles (01/2015 - 01/2015)|
|9.||Wang, Hongge: 2 articles (01/2015 - 01/2015)|
|10.||Niu, Jiajing: 2 articles (01/2015 - 01/2015)|
|2.||Parkinson Disease (Parkinson's Disease)
07/01/2013 - "Application of two-phase hollow fiber liquid phase microextraction coupled with high-performance liquid chromatography for the study of the echinacoside pharmacokinetics in Parkinson's disease rat plasma."
07/01/2013 - "The validated method has been successfully applied for pharmacokinetic studies of echinacoside in Parkinson's disease (PD) rat plasma after oral administration."
07/01/2013 - "A simple and solvent-minimized sample preparation technique based on two-phase hollow fiber liquid phase microextraction (HF-LPME) was developed and used to quantify the echinacoside in Parkinson's disease rat plasma following oral administration. "
07/01/2012 - "Selective protection of nigral dopaminergic neurons by echinacoside in a rat model of Parkinson disease induced by rotenone."
07/30/2010 - "Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease."
|3.||Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
05/01/2013 - "The aim of this study is to investigate the effect of echinacoside (ECH) on cholinergic neurotransmitter extracellular of hippocampus and striatum and its possible mechanisms of neuro-protective effect against vascular dementia rats. "
05/01/2013 - "The results suggested that echinacoside could promote the recovery of cholinergic neurotransmitter levels in vascular dementia rats' brain, which may be one of the mechanisms of neuro-protection."
05/01/2013 - "The results showed that the success rate of vascular dementia model was 83.08% after six weeks; the results also showed that echinacoside and galantamine could increase the content of ACh and reduce the content of Ch extracellular of hippocampus and striatum significantly and the AChE activity increased significantly compared with that of the model group. "
|4.||Metabolic Bone Diseases (Osteopenia)
01/01/2014 - "The main purpose of this study is to evaluate the effect of echinacoside (ECH) on hypoxia-induced proliferation of rat pulmonary artery smooth muscle cells (PASMCs) and the underlying mechanism. "
01/01/2014 - "Antiproliferative effect of echinacoside on rat pulmonary artery smooth muscle cells under hypoxia."
|2.||Neurotransmitter Agents (Neurotransmitter)
|3.||Caspase 3 (Caspase-3)
|4.||1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
|6.||Caspase 8 (Caspase-8)
|7.||Oleic Acid (Oleate)
|8.||Reactive Oxygen Species (Oxygen Radicals)
|9.||Oxidopamine (6 Hydroxydopamine)
|10.||1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)